Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHS-0214 versus Enbrel in rheumatoid arthritis with inadequate response to methotrexate
jRCT2080222570Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of GP2015 in rheumatoid arthritis (RA) (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
GP2015
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080222570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222570.